CONMED Financial Ratios
NYSE: CNMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CONMED ratio analysis
CONMED earned a net margin of 3.4% in FY 2025, down from 10.1% a year earlier. Gross margin was 54.6% compared with a median of 54.6% over the prior 9 years. Return on equity reached 4.6%, meaning CONMED generated 0.05 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.81 versus 0.94 the year before, and the current ratio was 2.14. At the end of FY 2025, CNMD traded at 26.8 times earnings; across the 9 fiscal years shown, its year-end P/E ranged from 16.0 to 350.0, with a median of 53.7. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
CONMED financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 26.83 | 15.99 | 53.68 | — | 73.07 | 350.00 | 114.55 | 44.21 | 25.87 | 84.94 |
| Price / sales | 0.91 | 1.60 | 2.70 | 2.55 | 4.09 | 3.71 | 3.30 | 2.04 | 1.79 | 1.61 |
| Price / book | 1.22 | 2.18 | 4.03 | 3.57 | 5.26 | 4.51 | 4.43 | 2.65 | 2.26 | 2.12 |
| Gross margin | 54.6% | 56.1% | 54.3% | 54.6% | 56.2% | 53.4% | 54.9% | 54.6% | 54.1% | 53.5% |
| Operating margin | 7.5% | 15.3% | 9.7% | 6.7% | 10.9% | 5.3% | 8.3% | 8.3% | 5.9% | 4.9% |
| Net margin | 3.4% | 10.1% | 5.2% | -7.7% | 6.2% | 1.1% | 3.0% | 4.8% | 7.0% | 1.9% |
| Free cash flow margin | 11.0% | 11.8% | 8.5% | 1.1% | 9.6% | 6.0% | 7.9% | 6.8% | 6.6% | 3.3% |
| Return on equity (ROE) | 4.6% | 13.8% | 7.7% | -10.8% | 8.0% | 1.3% | 4.0% | 6.2% | 8.8% | 2.5% |
| Return on assets (ROA) | 2.0% | 5.7% | 2.8% | -3.5% | 3.5% | 0.5% | 1.6% | 3.0% | 4.1% | 1.1% |
| Debt / equity | 0.81 | 0.94 | 1.17 | 1.41 | 0.87 | 1.06 | 1.08 | 0.69 | 0.77 | 0.86 |
| Current ratio | 2.14 | 2.30 | 1.98 | 1.96 | 2.34 | 2.19 | 2.11 | 2.33 | 2.38 | 2.90 |
| Revenue growth | 5.2% | 5.0% | 19.1% | 3.4% | 17.2% | -9.7% | 11.1% | 7.9% | 4.3% | 6.2% |
| EPS growth | -64.5% | 108.3% | — | -238.1% | 506.2% | -67.0% | -31.2% | -28.4% | 278.8% | -52.3% |